Navigation Links
Dr Reddys Launches New Drug In Its Urology Segment

Consolidating its position in the urology segment, pharma major Dr Reddys Laboratories Ltd has introduced a drug Alfuzosin Hydrochloride available// in extended release tablets of 10 mg dosage.

Alfuzosin Hydrochloride, introduced under the brand name 'Alfoo' is indicated for treatment of enlargement of prostate gland in ageing men known as Benign Prostatic Hyperplasia (BPH), a company release said.

The product was launched nationwide, and would further help the company consolidate its position in the urology segment which has over 10 products in the urology segment, the company informed the Bombay Stock Exchange.

The product is now available in over 5,700 retail counters across the nation and marketed by over 100 scientific business officers, it added.

The market size for the product as per April 2006 market data is valued at Rs 27 crore and the urology segment is estimated at Rs 65.08 crore.

Alfuzosin provides rapid relief from signs and symptoms of Benign Prostatic Hyperplasia (BPH) is a most common disorder among ageing men. The prevalence of BPH increases from 8 per cent in men between 31 and 40 years of age to 50 per cent in men between 51 and 60 years of age.

The shares of the company were trading at Rs 1,274.95, 0.07 per cent at the BSE

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
2. Serum Institute Launches New Tetanus-Diphtheria Vaccine
3. Scottish Health Minister Launches Organ Donor Plan
4. Pfizer Launches Viagra For Lung Disease In UK
5. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
6. PM Launches Healthcare Foundation For India
7. African Union Launches A Programme On Acceleration of HIV Prevention
8. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
9. Prince Harry Launches AIDS Charity In Memory Of Princess Diana
10. The British Medical Journal Launches A Health Website
11. APEC Launches Bird Flu Exercise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... Linda, Ca (PRWEB) , ... February 27, 2017 ... ... Life Sciences, provides an overview on laser diffraction analysis as a tool to ... its capabilities, significance and potential to obtain improved results and novel scientific findings. ...
(Date:2/27/2017)... , ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. ... has disclosed that despite scientific studies, the Center for Disease Control ( CDC ) ... disease . Kenneth B. Liegner, M.D. has compiled into a single volume a ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast ... in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the ... Mackenzie Alsager, showcases the Centre's commitment to innovation in drug rehab and alcohol ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, a ... an upgrade to the company's Yelp listing. Bay Area residents struggling from thinning ... as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular Unit ...
(Date:2/26/2017)... ... 25, 2017 , ... The February 13, 2017, assassination of Kim Jong-nam, the ... agents and the deadly use of chemical weapons. Many questions exist about the effect ... doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, and ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 2017 Mederi Therapeutics today announced the ... 2468 patients who received  Stretta Therapy  to treat ... Systematic Review and Meta-Analysis of Controlled and Prospective ... of Gastroesophageal Reflux Disease ", was published in ... , MD, head of the Esophageal and Swallowing ...
(Date:2/27/2017)... Feb. 27, 2017  International Biophysics Corporation, a global medical ... today announced a 34% revenue growth in 2016 when compared ... unit sales.  This growth was fueled by its AffloVest® sales ... to the expansion of its global sales of surgical product ... CEO, "As we enter our 25 th year in ...
(Date:2/27/2017)... 2017  Infinity Pharmaceuticals, Inc. (NASDAQ: INFI ... 37 th Annual Healthcare Conference on Monday, March ... Boston, MA. A live webcast of Infinity,s ... Infinity,s website at www.infi.com , and will be ... About Infinity,Infinity is an innovative biopharmaceutical company dedicated to ...
Breaking Medicine Technology: